2781 Stories, most recent news story added 8 minutes ago
Chemotherapy helps improve breast cancer survival in post-menopausal women, adding to a long-standing debate about how best to treat these women, U.S. researchers said on Thursday.
THURSDAY, Dec. 10 (HealthDay News) -- Adding chemotherapy to standard cancer-suppressing tamoxifen can boost survival in postmenopausal women with the most common type of breast cancer, known as estrogen receptor-positive, and it's best given before the tamoxifen regimen starts, according to a new study.
New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer.
Soy foods may be safe, and possibly even beneficial, for breast cancer survivors, a new study says.
THURSDAY, Dec. 10 (HealthDay News) -- Bone-building drugs used by tens of millions of women to fight osteoporosis also cut the risk of breast cancer, suggesting the drugs may play a dual role in keeping women healthy.
Post-menopausal women who have three to four alcoholic beverages a week of any sort have a significantly higher risk that their breast cancer will come back, U.S. researchers said Thursday.
Breast cancer survivors who have just a few alcoholic drinks per week are more likely than women who drink little or no alcohol to see their breast cancer return, according to research presented today at an annual meeting of breast cancer specialists.
THURSDAY, Dec. 10 (HealthDay News) -- Overeating and drinking even moderate amounts of alcohol may be bad news for women with breast cancer, new research suggests.
Pfizer's new breast cancer drug is shown to prevent relapse
Dec. 10 (Bloomberg) -- Bone-building drugs such as Merck & Co.’s Fosamax, Novartis AG’s Zometa and Roche Holding AG’s Boniva may cut older women’s risk of breast cancer, according to two studies presented today at a medical meeting in San Antonio.
Bone-building drugs taken by millions of women to prevent fractures and osteoporosis may also protect them against breast cancer, studies show.
Open slideshowReuters
Open slideshowAFP/Keystone/File
Open slideshowAFP/Keystone/File
